Literature DB >> 32224100

Anterior Chamber Angles after Intravitreal Injections for Macular Degeneration.

Bliss Elizabeth O'Bryhim1, Jonathan B Lin1, Kisha D Piggott1, P Kumar Rao1, Rajendra S Apte2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32224100      PMCID: PMC7354200          DOI: 10.1016/j.oret.2020.02.007

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN: 2468-6530


× No keyword cloud information.
  5 in total

1.  Ethnic difference of the anterior chamber area and volume and its association with angle width.

Authors:  Dandan Wang; Meng Qi; Mingguang He; Lingling Wu; Shan Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-31       Impact factor: 4.799

2.  Changes in angle configuration after phacoemulsification measured by anterior segment optical coherence tomography.

Authors:  Winifred P Nolan; Jovina L See; Tin Aung; David S Friedman; Yiong-Huak Chan; Scott D Smith; Ce Zheng; David Huang; Paul J Foster; Paul T K Chew
Journal:  J Glaucoma       Date:  2008-09       Impact factor: 2.503

3.  Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.

Authors:  Quan V Hoang; Luis S Mendonca; Kara E Della Torre; Jesse J Jung; Angela J Tsuang; K Bailey Freund
Journal:  Ophthalmology       Date:  2011-11-04       Impact factor: 12.079

Review 4.  The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review.

Authors:  Peter Bracha; Nicholas A Moore; Thomas A Ciulla; Darrell WuDunn; Louis B Cantor
Journal:  Surv Ophthalmol       Date:  2017-09-05       Impact factor: 6.048

5.  Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration.

Authors:  Joanne C Wen; Ester Reina-Torres; Joseph M Sherwood; Pratap Challa; Katy C Liu; Guorong Li; Jason Y H Chang; Scott W Cousins; Stefanie G Schuman; Priyatham S Mettu; W Daniel Stamer; Darryl R Overby; R Rand Allingham
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-03-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.